Reason for request
Inclusion on the list of medicines reimbursed by National Health Insurance and approved for hospital use.
Clinical Benefit
| Insufficient |
In the current state of the dossier and while awaiting the results of the VEG 108844 non-inferiority study comparing VOTRIENT with sunitinib, the Transparency Committee considers that the actual benefit is insufficient to justify reimbursement by National Health Insurance. |
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
cUSsjzAcpfmgR2kZ
